Date: Wednesday, May 25, 2022, 2:30 pm ET
Paragraph or two about your problem statement for the webcast.
The personalized nature of cell therapies means that organizations are required by regulators to demonstrate end-to-end visibility across the product supply chain, ensuring chain of custody, identity, and condition.
This presentation is based on a ResultWorks client, who is a T cell therapy company who had the objective of implementing a T cell tracking environment.
In this webcast, you will learn: